News

Study reveals how pancreatic tumors evade immunity using a sugar disguise, and how a new antibody restores immunity in mice.

Researchers reveal how melanoma evolves to resist immunotherapy, identifying a potential treatment strategy.

Some women undergo unnecessary mastectomy and chemotherapy, but a "labyrinth in a chip" could reveal which cancers need aggressive treatments.

Researchers have discovered that targeting PD-L1 recycling in myeloid cells enhances T-cell activation and boosts the effects of checkpoint blockade therapies. A new antibody, H1A, shows promise for improving treatment outcomes.

A new study has revealed widespread misbeliefs around the cancer risks of consuming alcohol.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response.

Researchers have developed a groundbreaking new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies.

A University of Michigan Health study finds that testing for TRIM63 overexpression in renal cell carcinoma can reveal previously undetected mutations, potentially opening the door to more treatment options for patients.

An under-appreciated cancer mutation has been found to block immune checkpoint inhibitor drugs, offering a new approach to treating "cold" tumors.

Bacterial metabolites queuine and preQ1 have been found to directly regulate protein synthesis in human cells, promoting or suppressing cell growth with implications for cancer therapy.